Call to Schedule Free Consultation at Over 80 Centers Worldwide!
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Autoimmune
Cardiovascular
Endocrine
Gastrointestinal
Liver
Musculoskeletal
Neurological
Other
Respiratory/Pulmonary
Reproductive
Renal/Kidney
Urologic
Written by Dr. David Greene, MD, PhD, MBA on August 4, 2026
Hidradenitis Suppurativa (often abbreviated as HS) is a chronic, recurrent inflammatory skin condition that originates in the terminal hair follicles. It most commonly affects skin-on-skin areas where apocrine sweat glands are concentrated, including the armpits (axilla), beneath the breasts (inframammary folds), and the groin.
For those living with HS, the condition often presents as painful nodules, abscesses, and deep, draining sinus tracts (tunneling) or fistulae beneath the skin. Because standard care can be challenging and often fails to provide complete relief, patients increasingly look toward regenerative medicine options like stem cell and exosome therapies.
Managing HS traditionally relies on a combination of medical and surgical interventions designed to suppress symptoms and manage flare-ups:
Chronic Antibiotic Regimens: Used to control secondary infections and reduce baseline inflammation, though prolonged use carries risks of antibiotic resistance and side effects.
Surgical Excision: Physical removal of affected tissue or unroofing of sinus tracts, which can require extended recovery times and leave significant scarring without preventing new lesions elsewhere.
Biologic Therapies: Targeted immune-suppressing medications that can help keep the disease partially in check, though some patients find them difficult to tolerate or experience diminishing effectiveness over time.
Despite these options, many individuals are left with persistent tunneling disease that resists complete healing. This ongoing frustration has pushed medical researchers to evaluate how regenerative medicine differs from traditional methods to address the underlying drivers of severe inflammatory diseases rather than just managing surface symptoms.
Medical research indicates that HS is primarily driven by an immune system dysregulation. Rather than being a simple bacterial infection or a hygiene issue, HS involves an abnormal response from immune cells surrounding the terminal hair follicles.
Studies have identified significant irregularities in various immune cell populations in HS patients, particularly involving T cells and T helper cells. When these immune cells go awry, they release high levels of pro-inflammatory cytokines, causing severe localized swelling, pain, tissue destruction, and the formation of chronic draining tracts.
Feature | Conventional HS Treatments | Regenerative Cell Therapy |
Primary Approach | Symptom suppression / Tissue removal | Targeted immune modulation |
Methods | Antibiotics, Biologics, Surgery | MSCs and Exosome Infusions/Injections |
Immune Target | Broad immune suppression | Balancing T-cell activity & inflammation |
Tissue Focus | Surgical excision of sinus tracts | Promoting natural tissue & fistula repair |
Mesenchymal stem cells (MSCs) and stem cell-derived exosomes possess biological properties that directly address the core mechanisms of HS:
A substantial body of basic science and animal research demonstrates that MSCs and exosomes excel at modulating overactive immune cells. Rather than shutting down the immune system completely, MSCs deposit signals that help reset irregular T-cell activity, reducing chronic auto-inflammatory signaling. To better understand these signaling mechanisms, many patients explore how exosomes play into regenerative therapy to coordinate cellular repair.
Multiple clinical studies evaluating MSCs and exosomes for fistulizing conditions (such as fistulizing Crohn’s disease) show that local and systemic delivery of these biologics can significantly aid in closing and healing complex sinus tracts. The growth factors and signaling proteins contained in stem cells promote tissue regeneration and collagen remodeling.
Stem cells respond dynamically to inflammatory environments. When introduced into areas of tissue damage, they detect inflammatory cytokines and release anti-inflammatory signals to help normalize the microenvironment. This broader mechanism explains why stem cell therapy works for a wide range of diseases marked by autoimmune or hyper-inflammatory responses.
It is important for patients researching regenerative options to understand the current state of scientific evidence:
Preclinical Evidence: Extensive laboratory and animal model studies confirm that MSCs effectively regulate T-cell dysregulation and decrease localized inflammation.
Clinical Evidence in Related Conditions: Clinical trials using MSCs for complex fistulae in other inflammatory diseases have shown strong success rates in healing persistent tracts.
Specific HS Research: Large-scale, randomized clinical trials specifically focused on stem cell and exosome therapy exclusively for Hidradenitis Suppurativa are still limited. However, real-world clinical experience and pilot applications for autoimmune disease patients who benefit from stem cell therapy report encouraging patient outcomes.
If you or a loved one are struggling with persistent Hidradenitis Suppurativa that has failed to resolve with standard therapies, learning how to choose the right stem cell clinic is an essential step in finding a safe, compliant treatment provider.
R3 Stem Cell provides individual consultations to help determine whether stem cell or exosome therapies are appropriate for your specific health needs. Contact our team to schedule a free consultation and receive educational resources, including a copy of Stem Cell Genius.
Phone: +1 844-GET-STEM
Consultation: Complimentary medical candidate evaluation
Contact Us